[The clinical evaluation of the efficacy of Isoket in patients with vasospastic stenocardia].
Bobrov
V A
VA
Simorot
V N
VN
D000328:Adult; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D002046:Bupranolol / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D003329:Coronary Vasospasm / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D004338:Drug Combinations; C011882:bupranolol, isosorbide dinitrate drug combination; D002046:Bupranolol; D009543:Nifedipine; D007548:Isosorbide Dinitrate
Klinicheskaia otsenka éffektivnost' izoketa u bol'nykh s vazospasticheskoĭ stenokardieĭ.